# Short Versus Long-term Levetiracetam in Brain Tumors

> **NCT06442748** · PHASE3 · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 604 (estimated)

## Conditions studied

- Seizures
- Brain Tumors
- Antiepileptics
- Levetiracetam

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT06442748
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-04
- **Primary completion:** 2031-06-01
- **Final completion:** 2031-06-01
- **Target enrollment:** 604 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06442748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06442748, "Short Versus Long-term Levetiracetam in Brain Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06442748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*